Citation

Letavic MA, Savall BM, Allison BD, Aluisio L, Andres JI, De Angelis M, Ao H, Beauchamp DA, Bonaventure P, Bryant S, Carruthers NI, Ceusters M, Coe KJ, Dvorak CA, Fraser IC, Gelin CF, Koudriakova T, Liang J, Lord B, Lovenberg TW, Otieno MA, Schoetens F, Swanson DM, Wang Q, Wickenden AD, Bhattacharya A.: 4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate. J Med Chem, Volume 60 (11), 2017

Authors

Allison BD, Aluisio L, Andrés JI, Ao H, Beauchamp DA, Bhattacharya A., Bonaventure P, Bryant S, Carruthers NI, Ceusters M, Coe KJ, De Angelis M, Dvorak CA, Fraser IC, Gelin CF, Koudriakova T, Letavic MA, Liang J, Lord B, Lovenberg TW, Otieno MA, Savall BM, Schoetens F, Swanson DM, Wang Q, Wickenden AD

Journal

J Med Chem

Year

2017

DOI

10.1021/acs.jmedchem.7b00408

PubMed

28493698

Machine-readable

REST APIRDF